Covidien Recalls Syringes With Chinese-Produced Heparin
This article was originally published in PharmAsia News
Executive Summary
Covidien announced a recall of its pre-filled syringes containing heparin, citing the same contamination possibility involved in recalls of the drug itself. Covidien, formerly Tyco Healthcare, said it acted after being notified by Scientific Protein Laboratories the China-produced heparin in the syringes also contained a contaminant blamed for deaths of patients receiving the blood-clotting drug. The voluntary Covidien recall was announced in conjunction with the U.S. FDA. (Click here for more